Developing solutions for osteoporosis management
& fracture prevention
The Asia Pacific Consortium on Osteoporosis (APCO) comprises Osteoporosis experts from several countries in Asia Pacific, charged with developing tangible solutions to the substantive challenges involving osteoporosis management and fracture prevention in this most populated and fastest growing region of the world.
Representing multiple medical and surgical specialties, the Consortium aims to create a pan-Asia Pacific “Framework” for the introduction and implementation of minimum clinical standards for the screening, diagnosis and management of osteoporosis targeting a broad range of high-risk groups.
0
Osteoporosis experts from 19 countries and regionsAbout APCO
Representing Osteoporosis experts from 19 countries and regions
APCO (Asia Pacific Consortium on Osteoporosis) is charged with developing tangible solutions to the substantive challenges involving osteoporosis management and fracture prevention.
APCO Framework
A pan-Asia Pacific “Framework” for the implementation of minimum clinical standards across the region
The APCO Framework will propose clear and concise standards of care involving the screening, diagnosis and management of osteoporosis, targeting a broad range of high-risk groups. These standards will provide a benchmark for the provision of quality care across Asia Pacific.
About Osteoporosis
A common disease characterised by porous brittle bones, low bone density and quality, and structural deterioration
Osteoporosis is defined as having a bone mineral density (BMD) 2.5 standard deviations below the average value of a young healthy person, leading to enhanced bone fragility, and increased fracture risk. More than 200 million people worldwide live with osteoporosis.
Guidelines
Current gaps and unmet needs relating to osteoporosis clinical guidelines in the Asia Pacific region
Although clinical guidelines for managing osteoporosis are available in many countries throughout Asia Pacific, their lack of implementation-related guidance poses the biggest challenge for the optimal diagnosis and management of osteoporosis.
BLOG
Modern day Alchemy? Bisphosphonates – the Elixir of Life?
Charting a path for osteoporosis care in Developing countries – spotlight on Việt Nam
Speaking up for the ‘silent disease’ in the Asia Pacific
Osteoporosis and fragility fractures – a family affair
Goal Directed Therapy in osteoporosis: a target in sight or still a pipe-dream?
Breakable bones and genes – How can doctors utilise genes for fracture risk assessment?
Innovative approaches to driving public awareness of bone health
